BioSpaceOriginal article
FDA issues warning over Eurofins’ selective recording that "compromises" data
RegulatorynegativeNegative
AI Analysis
Summary
The FDA issued a warning to analytical testing provider Eurofins over selective data recording and inconsistent reporting at a Pennsylvania site, which compromised microbiological analyses of components and drug products tested for customers.
Outcome Details
FDA issued a warning over selective data recording and inconsistent reporting at a Pennsylvania Eurofins site, which compromised the integrity of microbiological analyses of components and drug products run for customers.
Importance:5/10
Sentiment:
-0.50
FDA warning letterdata integrityEurofinsCRO/CDMOmicrobiological testingquality controlcGMP compliance
Read the original article
Published by BioSpace on October 16, 2026 12:10 PM